Reuters -- An experimental rheumatoid arthritis drug being developed by Pfizer Inc was effective as a stand-alone and in combination with a standard treatment for the disease, according to final analysis of data from a pair of mid-stage studies.
Reuters -- An experimental rheumatoid arthritis drug being developed by Pfizer Inc was effective as a stand-alone and in combination with a standard treatment for the disease, according to final analysis of data from a pair of mid-stage studies.
